| Sign In to gain access to subscriptions and/or personal tools. |
Rational therapy of mixed dyslipidaemia in a patient with diabetesUniversity of Texas Health Science Center and Medical Director, Texas Diabetes Institute, 701 S. Zarzamora, San Antonio, TX 78207, USA, Charles.Reasner{at}uhs-sa.com Diabetic dyslipidaemia refers to the triad of elevated levels of triglycerides and small, dense LDL-C particles and low levels of HDL-C. These lipid abnormalities are largely responsible for the increased risk of cardiovascular complications in patients with diabetes. This case study outlines a rational approach to the treatment of each of these lipid abnormalities and emphasises the importance of both lowering the LDL-C and raising the HDL-C in high-risk individuals. Combination drug therapy will often be necessary to achieve treatment goals in these patients.
Key Words: diabetic dyslipidaemia atherogenic dyslipidaemia statins fibrates niacin diabetes.
The British Journal of Diabetes & Vascular Disease, Vol. 7, No. 1,
25-30 (2007) |
|||